Funda Meric-Bernstam is the Chair of the Department of Investigational Cancer Therapeutics - Pase I Program at MD Anderson Cancer Center, the Medical Director of the Institute for Personalized Cancer Therapy, and The Nelli B. Connally Chair in Breast Cancer. She is a clinical trialist with a focus on decision support for precision oncology, biomarker-driven clinical trials, and antibody-drug conjugates. She is a phyusician-scientist with a basic and translational research program focused on cell signaling, biomarker discover and molecular therapeutics with focus on patient-derived models. She will be presenting: Advances in Personalized Cancer Therapy.